Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

43 trials with published results (8%)

Research Maturity

260 completed trials (49% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.5%

34 terminated out of 527 trials

Success Rate

88.4%

+1.9% vs benchmark

Late-Stage Pipeline

4%

19 trials in Phase 3/4

Results Transparency

17%

43 of 260 completed with results

Key Signals

43 with results88% success34 terminated

Data Visualizations

Phase Distribution

271Total
Not Applicable (202)
Early P 1 (1)
P 1 (17)
P 2 (32)
P 3 (11)
P 4 (8)

Trial Status

Completed260
Unknown87
Recruiting78
Terminated34
Not Yet Recruiting29
Withdrawn18

Trial Success Rate

88.4%

Benchmark: 86.5%

Based on 260 completed trials

Clinical Trials (527)

Showing 20 of 20 trials
NCT07081711Recruiting

Longitudinal Validation of CIRC Technologies

NCT05213598RecruitingPrimary

Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment

NCT06711666RecruitingPrimary

Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease

NCT01952171CompletedPrimary

The Genetic Basis of Congenital Heart Disease in Africa

NCT07732244Not ApplicableRecruiting

Evaluating a Wireless NIRS Device in the Neonatal Intensive Care Unit

NCT07706140Not Yet Recruiting

Observational Data Collection for Blood Hemoglobin Algorithm Validation in Pediatrics

NCT06267430Not ApplicableActive Not RecruitingPrimary

Learning by Heart: The Effectiveness of an EF Training Program for Pre-schoolers With a Severe CHD

NCT07700459Not ApplicableNot Yet RecruitingPrimary

Exercise Prehabilitation in Congenital Heart Disease

NCT07716488Not ApplicableRecruiting

Screening for Disorders of Lipid Metabolism and Familial Hyperlipidemia in Children and Adolescents With Increased Cardiovascular Risk Due to Chronic Diseases Such as Congenital Heart Disease, Chronic Inflammatory Bowel Disease, Celiac Disease and Rheumatic Disorders

NCT05006404Not ApplicableActive Not RecruitingPrimary

Autus Valve Pivotal Study

NCT07466745Not ApplicableNot Yet RecruitingPrimary

Autus Valve Continued Access Study (CAS)

NCT03152773Not ApplicableTerminated

Heart Catheterization Using Magnetic Resonance Imaging (MRI) Fluoroscopy and Passive Guidewires

NCT06969378Not ApplicableWithdrawn

Empiric Pulsed Field Pulmonary Vein Isolation During Atrial Tachycardia Ablation in Adults With Congenital Heart Disease

NCT05902013Not ApplicableCompletedPrimary

Video Laryngoscopy Versus Direct Laryngoscopy for Nasotracheal Intubation

NCT05869825Not ApplicableRecruitingPrimary

HFNC vs NIPPV Following Extubation

NCT03322345Terminated

Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy

NCT07697755Not ApplicableNot Yet Recruiting

Interoceptive Intervention for Congenital Heart Disease

NCT06193863Active Not Recruiting

An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure

NCT05670132Not ApplicableRecruitingPrimary

Neuro-cardiac Rehabilitation in Youth With Congenital Heart Disease (QUALINEUROREHAB)

NCT06650787Not ApplicableCompletedPrimary

Application of Ultrasound Technique in Locating the End of the Gastric Tube in Children Aged 0-6 Years

Scroll to load more

Research Network

Activity Timeline